用阿片类药物对抗剂治疗分离性症状:系统性审查
Irene Escamilla1,2, Nerea Juan1,2, Celeste Peñalva1,2
1TXP Research Group. Department of Medicine and Surgery, Universidad Cardenal Herrera-CEU, CEU Universities, Castellón de la Plana, Spain.
European journal of psychotraumatology
|October 20, 2023
概括
阿片类药物对抗剂在治疗分离性症状方面表现有前途,在分析中观察到中等到大效果大小. 由于研究的局限性和异质性,需要进一步的研究.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 临床指导方针对分离主要建议心理治疗.
- 精神活性药物在临床实践中用于解离.
- 理论上,阿片类对抗剂通过调节内源性阿片类系统来治疗解离.
研究的目的:
- 进行对阿片类药物对抗剂对分离性症状的证据的元分析.
- 评估纳尔特雷,纳洛和纳尔梅芬在治疗分离的疗效.
主要方法:
- 按照PRISMA指南进行系统审查和元分析.
- 在多个科学数据库 (PubMed,Scopus等) 进行的搜索. ) 的情况.
- 包括5项与154名参与者进行的比较研究.
主要成果:
- 发现阿片类药物对抗剂在减少分离症状方面具有显著的治疗效果 (聚合d = 1.46).
- 在包括的研究中观察到很高的异质性 (Q = 66.89,p < .001).
- 指出了潜在的出版偏见.
结论:
- 阿片类药物抗剂,特别是纳尔特雷,显示出治疗分离性症状的潜力.
- 由于数据有限和研究异质性,应谨慎解释结果.
- 需要进一步的研究来证实有效性和最佳使用.
相关概念视频
Opioid Analgesics: Synthetic and Semisynthetic Opioids
311
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
311
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
214
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
214
Analgesia and Pain Management
636
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
636
Drugs for Treatment of Diarrhea-Predominant IBS
186
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
186
Dissociative Disorders
122
Dissociative disorders represent complex psychological conditions characterized by disruptions in consciousness, memory, identity, or perception. These disruptions cause individuals to experience a disconnection from their thoughts, emotions, and memories. The phenomenon is not merely an occasional lapse in attention but a profound alteration in mental functioning that can severely impact daily life.
Dissociative Fugue
A hallmark feature of dissociative disorders is the dissociative fugue...
Dissociative Fugue
A hallmark feature of dissociative disorders is the dissociative fugue...
122
Opioid Receptors: Overview
939
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
939


